Integral Diagnostics Limited
ITGDF
$1.00
-$1.06-51.41%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.12% | 42.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.12% | 42.51% | |||
| Cost of Revenue | 2.12% | 40.93% | |||
| Gross Profit | 2.12% | 46.06% | |||
| SG&A Expenses | 2.12% | 29.80% | |||
| Depreciation & Amortization | 2.12% | 35.08% | |||
| Other Operating Expenses | 2.12% | 37.70% | |||
| Total Operating Expenses | 2.12% | 39.44% | |||
| Operating Income | 2.12% | 77.52% | |||
| Income Before Tax | 2.12% | 2,718.90% | |||
| Income Tax Expenses | 2.12% | 646.25% | |||
| Earnings from Continuing Operations | 2.12% | 1,367.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -2.18% | -- | |||
| Net Income | 2.12% | 1,332.48% | |||
| EBIT | 2.12% | 77.52% | |||
| EBITDA | 2.12% | 39.10% | |||
| EPS Basic | 2.33% | 960.00% | |||
| Normalized Basic EPS | 1.90% | 5,166.67% | |||
| EPS Diluted | 2.33% | 960.00% | |||
| Normalized Diluted EPS | 1.94% | 5,066.67% | |||
| Average Basic Shares Outstanding | 0.00% | 47.77% | |||
| Average Diluted Shares Outstanding | 0.00% | 50.68% | |||
| Dividend Per Share | 2.40% | 54.32% | |||
| Payout Ratio | 0.00% | 1.08% | |||